MDxHealth SA
MDXH
$2.19
-$0.018-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.74M | 22.16M | 19.83M | 19.40M | 14.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.74M | 22.16M | 19.83M | 19.40M | 14.70M |
| Cost of Revenue | 9.22M | 8.87M | 7.77M | 6.73M | 5.99M |
| Gross Profit | 15.52M | 13.29M | 12.06M | 12.67M | 8.72M |
| SG&A Expenses | 15.57M | 16.48M | 15.39M | 15.21M | 14.27M |
| Depreciation & Amortization | 1.33M | 1.12M | 1.13M | 4.49M | 1.12M |
| Other Operating Expenses | 441.00K | -40.00K | -9.00K | -193.00K | 724.00K |
| Total Operating Expenses | 29.35M | 29.33M | 26.44M | 25.70M | 23.42M |
| Operating Income | -4.61M | -7.18M | -6.60M | -6.31M | -8.72M |
| Income Before Tax | -6.79M | -11.53M | -8.51M | -10.72M | -11.71M |
| Income Tax Expenses | 48.00K | -- | -- | 1.00K | -- |
| Earnings from Continuing Operations | -6.84M | -11.53M | -8.51M | -10.72M | -11.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.84M | -11.53M | -8.51M | -10.72M | -11.71M |
| EBIT | -4.61M | -7.18M | -6.60M | -6.31M | -8.72M |
| EBITDA | -2.42M | -5.38M | -4.70M | -4.72M | -7.08M |
| EPS Basic | -0.14 | -0.42 | -0.31 | -0.39 | -0.53 |
| Normalized Basic EPS | 0.00 | -0.16 | -- | -0.04 | -- |
| EPS Diluted | -0.14 | -0.42 | -0.31 | -0.39 | -0.53 |
| Normalized Diluted EPS | 0.00 | -0.16 | -- | -0.04 | -- |
| Average Basic Shares Outstanding | 48.86M | 27.45M | 27.45M | 27.49M | 22.09M |
| Average Diluted Shares Outstanding | 48.86M | 27.45M | 27.45M | 27.49M | 22.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |